Lohxa, LLC – FDA 483, Mar 22, 2019
An FDA inspection of Lohxa, LLC, a drug repacker in Worcester, MA, revealed significant deficiencies in its quality systems and manufacturing processes. The firm failed to adequately investigate product complaints, lacked stability data for repackaged products, and did not properly qualify or calibrate equipment. Other critical issues included unvalidated repackaging processes, inadequate cleaning procedures, poor change control, insufficient record retention, incomplete master batch records, and a lack of environmental monitoring justification.
- Person
ID · f0e0080a-f100-4c33-ba93-6e6a6aad35ba
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.